Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer

Published:2010 Issue:3-4 Volume:79 Page:197-203
ISSN:1423-0232
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Stemmler Hans-Joachim,Harbeck Nadia,Gröll de Rivera Isolde,Vehling Kaiser Ursula,Rauthe Gerhard,Abenhardt Wolfgang,Artmann Almut,Sommer Harald,Meerpohl Hans-Gerd,Kiechle Marion,Heinemann Volker

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systemic review of taxanes and their side effects in metastatic breast cancer;Frontiers in Oncology;2022-10-11

2. Treatment of drug-induced immune thrombocytopenias;Haematologica;2022-05-19

3. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies;Haematologica;2022-05-19

4. The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials;BMC Cancer;2022-01-25

5. Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia;Expert Review of Hematology;2021-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP